These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21486790)

  • 41. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man.
    Grassi G; Bolla G; Seravalle G; Turri C; Lanfranchi A; Mancia G
    Clin Sci (Lond); 1997 Mar; 92(3):285-9. PubMed ID: 9093009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposition of endogenous adrenaline compared to noradrenaline released by cardiac sympathetic nerves in the anaesthetized dog.
    Eisenhofer G; Smolich JJ; Esler MD
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):160-71. PubMed ID: 1570020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noradrenaline spillover and microneurography measurements in patients with primary hypertension.
    Jennings GL
    J Hypertens Suppl; 1998 Aug; 16(3):S35-8. PubMed ID: 9747908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits.
    Eisenhofer G; Cox HS; Esler MD
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):328-35. PubMed ID: 2280799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man.
    Wallin BG; Sundlöf G; Eriksson BM; Dominiak P; Grobecker H; Lindblad LE
    Acta Physiol Scand; 1981 Jan; 111(1):69-73. PubMed ID: 7223453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.
    Krum H; Lambert E; Windebank E; Campbell DJ; Esler M
    Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1706-12. PubMed ID: 16284232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bursting into space: alterations of sympathetic control by space travel.
    Eckberg DL;
    Acta Physiol Scand; 2003 Mar; 177(3):299-311. PubMed ID: 12609000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Desipramine inhibits sympathetic nerve activity in the rabbit.
    Sazbo B; Schultheiss A
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):469-76. PubMed ID: 2255338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure.
    Lambert E; Dawood T; Straznicky N; Sari C; Schlaich M; Esler M; Lambert G
    J Hypertens; 2010 Mar; 28(3):543-50. PubMed ID: 20139772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.
    Kaye DM; Lambert GW; Lefkovits J; Morris M; Jennings G; Esler MD
    J Am Coll Cardiol; 1994 Mar; 23(3):570-8. PubMed ID: 8113536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
    Niederhoffer N; Szabo B
    Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased cardiac sympathetic nervous activity in patients with unstable coronary heart disease.
    McCance AJ; Thompson PA; Forfar JC
    Eur Heart J; 1993 Jun; 14(6):751-7. PubMed ID: 8325300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension.
    Rumantir MS; Jennings GL; Lambert GW; Kaye DM; Seals DR; Esler MD
    J Hypertens; 2000 Jun; 18(6):717-23. PubMed ID: 10872556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk.
    Lambert E; Dawood T; Schlaich M; Straznicky N; Esler M; Lambert G
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):503-7. PubMed ID: 18307750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relevance of plasma noradrenaline concentrations to estimate autonomic effects of antihypertensive drugs.
    Elmfeldt D; Elvelin L; Nordlander M
    Blood Press; 1994 Nov; 3(6):356-63. PubMed ID: 7704282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities.
    Floras JS
    Acta Physiol Scand; 2003 Mar; 177(3):391-8. PubMed ID: 12609011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of low- and high-intensity lower body negative pressure on noradrenaline and adrenaline kinetics in humans.
    Jacobs MC; Goldstein DS; Willemsen JJ; Smits P; Thien T; Lenders JW
    Clin Sci (Lond); 1996 May; 90(5):337-43. PubMed ID: 8665770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure.
    Rundqvist B; Elam M; Bergmann-Sverrisdottir Y; Eisenhofer G; Friberg P
    Circulation; 1997 Jan; 95(1):169-75. PubMed ID: 8994433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Augmented single-unit muscle sympathetic nerve activity in heart failure with chronic atrial fibrillation.
    Ikeda T; Murai H; Kaneko S; Usui S; Kobayashi D; Nakano M; Ikeda K; Takashima S; Kato T; Okajima M; Furusho H; Takamura M
    J Physiol; 2012 Feb; 590(3):509-18. PubMed ID: 22144576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure.
    Notarius CF; Azevedo ER; Parker JD; Floras JS
    Eur Heart J; 2002 May; 23(10):800-5. PubMed ID: 12009720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.